Clinical Trial Update: Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.

View source ↗

Summary

This entry covers the MANTLE-FIRST BIO clinical study, which aims to glean biological insights from first relapsed/refractory mantle cell lymphoma patients. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Mantle Cell Lymphoma | Status: ACTIVE_NOT_RECRUITING